EPTIS
BAM Logo

Methamphetamine / Methylenedioxymethamphetamine (MDMA) in swabs

EPTIS factsheet 458147 | Last revision 2021-01-27 | URL: https://www.eptis.bam.de/pts458147 https://www.eptis.bam.de/pts458147

PT provider
PT provider National Measurement Institute, Australia National Measurement Institute, Australia
Based in Australia
Language(s) English
Remarks This study will occur in June 2021, AQA 21-21. Permits to hold controlled substances will need to be obtained prior to sending samples.
Keywords
Product groups Pharmaceutical products, drugs
Testing fields Analytical chemistry
Technical details
Test item Tested property Testing method
Swab Methamphetamine -
Methylenedioxymethamphetamine (MDMA) -
Aims of the PT scheme
Target group of participants Environmental laboratories involved in the investigation and clean-up of Clandestine laboratories associated with illicit drugs manufacture
Linked to specific legislation / standards Clandestine Drug Laboratory Remediation Guidelines 2011
Additional, subsidiary aims
Number of participants 20 - 30
Accredited or otherwise reviewed by a 3rd party

Accredited by NATA on the basis of ISO17043

Operation is commissioned / requested by
Fees and frequency
Participation fee AUD 836 Australia (incl GST), AUD 1340 International.
Regularly operated Yes (Based on Participants Request)
Year of first operation 2018
Contact details of the PT provider
Provider Contact person
National Measurement Institute, Australia
105 Delhi Road
NORTH RYDE NSW 2113
Australia

Phone: +61 (0)2 94490111
Fax:
Web: http://www.measurement.gov.au http://www.measurement.gov.au
Mrs Luminita Antin
Phone: +61 02 94490205
Fax:
Email: luminita.antin@measurement.gov.au luminita.antin@measurement.gov.au
If you find any mistakes please contact the responsible EPTIS coordinator in Australia, Ms Luminita Antin. Ms Luminita Antin.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21